ltztherapeutics — LTZ Therapeutics is a clinical-stage immunotherapy biotechnology company developing novel myeloid engager therapeutics for cancer treatment. Its platform focuses on the direct engagement of myeloid cells with target cells to boost anti-tumor immunity, with lead candidate LTZ-232 receiving FDA IND clearance in July 2026 for… - View it on GitHub